ReviewCardiovascular toxicology2026
The Neuroimmune Mechanisms Linking Smoking and Infection to Atherosclerosis: Chronic vs. Surge.
Review in Cardiovascular toxicology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The pathogenesis of atherosclerosis has progressively shifted from a lipid-centric model to one that recognizes inflammation as the central driver. Smoking is a well-established chronic risk factor, whereas acute infections are increasingly recognized as transient triggers of acute cardiovascular events. This review synthesizes the distinct yet overlapping mechanisms by which chronic smoking and acute infections contribute to atherogenesis and plaque destabilization within an integrated neuroimmune framework. This narrative review was developed using AI-assisted literature search tools (ChatGPT, OpenAI; Claude, Anthropic) to identify relevant publications from 1990 to 2025. All references were independently verified using PubMed and original source links. Selection prioritized mechanistic studies addressing inflammatory pathways, endothelial dysfunction, and immune modulation. Smoking promotes atherogenesis through sustained endothelial injury, lipoprotein oxidation, chronic sympathetic activation, and hematopoietic reprogramming, favoring proinflammatory monocyte mobilization. Infections elicit acute cytokine surges, sympathetic-mediated macrophage activation, and prothrombotic cascades that destabilize preexisting plaques. Smoking contributes to plaque initiation and growth, whereas infections primarily act as event triggers. Atherosclerosis emerges from chronic and episodic inflammatory processes with distinct temporal profiles. Smoking is a continuous driver of plaque formation, whereas acute infections promote plaque destabilization. Future research should examine their interplay, particularly in smokers exposed to recurrent or low-grade infectious states.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.